TickerFacts.

Turn Therapeutics Inc. (TTRX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$4.69M
As of 2025-12-31
$686.9K
As of 2026-06-30
2024-12-31: -$177.4K2025-12-31: $4.69M$4.69M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$4.69Mn/m2026-03-31, Balance as of period end
2024-12-31-$177.4Kn/a2026-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Turn Therapeutics Inc. (TTRX)2025-12-31$4.69Mn/m
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$11.66M+205.8%
Imunon, Inc. (IMNN)2025-12-31$7.06M+66.4%
PRF Technologies Ltd. (PRFX)2025-12-31$8.54M+368.4%
Nomad Power Solutions, Inc. (NMAD)2025-12-31$9.66Mn/m
Revelation Biosciences, Inc. (REVB)2025-12-31$8.86M+88.2%
Curanex Pharmaceuticals Inc (CURX)2025-12-31$11.22Mn/m
Propanc Biopharma, Inc. (PPCB)2026-06-30$9.40M-32.4%
PMGC Holdings Inc. (ELAB)2025-12-31$7.84M+17.7%

Compare TTRX, ANEB, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗